Biolojic Design, Ltd. is a biotechnology company specializing in the development of computationally designed antibodies for therapeutic purposes. They leverage advanced computational biology and machine learning to create novel antibodies that can target a wide range of diseases, including cancer and autoimmune disorders. Founded by a team of experts in computational biology and immunotherapy, the company has made significant strides in the biopharmaceutical industry by focusing on precision medicine. Their innovative approach not only accelerates drug discovery but also aims to improve the efficacy and safety of treatments.